Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Impact of culture medium on CD4(+) CD25(high)CD127(lo/neg) Treg expansion for the purpose of clinical application.

Gołąb K, Krzystyniak A, Marek-Trzonkowska N, Misawa R, Wang LJ, Wang X, Cochet O, Tibudan M, Langa P, Millis JM, Trzonkowski P, Witkowski P.

Int Immunopharmacol. 2013 Jul;16(3):358-63. doi: 10.1016/j.intimp.2013.02.016. Epub 2013 Mar 4.

PMID:
23466550
2.

Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.

Ukena SN, Höpting M, Velaga S, Ivanyi P, Grosse J, Baron U, Ganser A, Franzke A.

Exp Hematol. 2011 Dec;39(12):1152-60. doi: 10.1016/j.exphem.2011.08.010. Epub 2011 Aug 22.

PMID:
21864487
3.

Expansion of human regulatory T-cells from patients with type 1 diabetes.

Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA.

Diabetes. 2009 Mar;58(3):652-62. doi: 10.2337/db08-1168. Epub 2008 Dec 15.

4.

Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.

Singh AK, Seavey CN, Horvath KA, Mohiuddin MM.

Xenotransplantation. 2012 Mar-Apr;19(2):102-11. doi: 10.1111/j.1399-3089.2012.00697.x.

PMID:
22497512
5.

Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distribution.

Carlens S, Gilljam M, Remberger M, Aschan J, Christensson B, Dilber MS.

Exp Hematol. 2000 Oct;28(10):1137-46.

PMID:
11027832
6.

Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral blood.

Fan H, Yang J, Hao J, Ren Y, Chen L, Li G, Xie R, Yang Y, Gao F, Liu M.

Immunology. 2012 Jun;136(2):218-30. doi: 10.1111/j.1365-2567.2012.03573.x.

7.

Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.

Yang J, Fan H, Hao J, Ren Y, Chen L, Li G, Xie R, Yang Y, Qian K, Liu M.

Transfusion. 2012 Jun;52(6):1333-47. doi: 10.1111/j.1537-2995.2011.03448.x. Epub 2011 Nov 21.

PMID:
22098312
8.

Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.

Canavan JB, Scottà C, Vossenkämper A, Goldberg R, Elder MJ, Shoval I, Marks E, Stolarczyk E, Lo JW, Powell N, Fazekasova H, Irving PM, Sanderson JD, Howard JK, Yagel S, Afzali B, MacDonald TT, Hernandez-Fuentes MP, Shpigel NY, Lombardi G, Lord GM.

Gut. 2016 Apr;65(4):584-94. doi: 10.1136/gutjnl-2014-306919. Epub 2015 Feb 24.

9.

Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.

Hoffmann P, Eder R, Boeld TJ, Doser K, Piseshka B, Andreesen R, Edinger M.

Blood. 2006 Dec 15;108(13):4260-7. Epub 2006 Aug 17.

10.

Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter.

Mayer E, Bannert C, Gruber S, Klunker S, Spittler A, Akdis CA, Szépfalusi Z, Eiwegger T.

PLoS One. 2012;7(1):e29355. doi: 10.1371/journal.pone.0029355. Epub 2012 Jan 17.

11.

The time is crucial for ex vivo expansion of T regulatory cells for therapy.

Marek N, Bieniaszewska M, Krzystyniak A, Juścińska J, Myśliwska J, Witkowski P, Hellmann A, Trzonkowski P.

Cell Transplant. 2011;20(11-12):1747-58. doi: 10.3727/096368911X566217. Epub 2011 Apr 1.

PMID:
21457615
12.

Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).

Cao T, Soto A, Zhou W, Wang W, Eck S, Walker M, Harriman G, Li L.

Cell Immunol. 2009;258(1):65-71. doi: 10.1016/j.cellimm.2009.03.013. Epub 2009 May 1.

PMID:
19410243
13.

Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.

Di Caro V, D'Anneo A, Phillips B, Engman C, Harnaha J, Lakomy R, Styche A, Trucco M, Giannoukakis N.

Clin Exp Immunol. 2011 Jul;165(1):60-76. doi: 10.1111/j.1365-2249.2011.04334.x. Epub 2011 Mar 17.

14.

Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.

Teng L, Liu L, Su Y, Yuan X, Li J, Fu Q, Chen S, Wang C.

J Surg Res. 2011 Dec;171(2):797-806. doi: 10.1016/j.jss.2010.03.044. Epub 2010 Apr 15.

PMID:
20538297
15.

The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells.

Mittag D, Scholzen A, Varese N, Baxter L, Paukovics G, Harrison LC, Rolland JM, O'Hehir RE.

J Immunol. 2010 May 1;184(9):4708-16. doi: 10.4049/jimmunol.0901036. Epub 2010 Mar 22.

16.

FOXP3 promoter demethylation reveals the committed Treg population in humans.

Janson PC, Winerdal ME, Marits P, Thörn M, Ohlsson R, Winqvist O.

PLoS One. 2008 Feb 20;3(2):e1612. doi: 10.1371/journal.pone.0001612.

17.

CD4(+)CD25 (+)CD127 (low/-) T cells: a more specific Treg population in human peripheral blood.

Yu N, Li X, Song W, Li D, Yu D, Zeng X, Li M, Leng X, Li X.

Inflammation. 2012 Dec;35(6):1773-80. doi: 10.1007/s10753-012-9496-8.

PMID:
22752562
18.

Mesenchymal cells recruit and regulate T regulatory cells.

Di Ianni M, Del Papa B, De Ioanni M, Moretti L, Bonifacio E, Cecchini D, Sportoletti P, Falzetti F, Tabilio A.

Exp Hematol. 2008 Mar;36(3):309-18. doi: 10.1016/j.exphem.2007.11.007.

PMID:
18279718
19.

Generation of induced regulatory T cells from primary human naïve and memory T cells.

Ellis GI, Reneer MC, Vélez-Ortega AC, McCool A, Martí F.

J Vis Exp. 2012 Apr 16;(62). pii: 3738. doi: 10.3791/3738.

20.

CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.

Shen LS, Wang J, Shen DF, Yuan XL, Dong P, Li MX, Xue J, Zhang FM, Ge HL, Xu D.

Clin Immunol. 2009 Apr;131(1):109-18. doi: 10.1016/j.clim.2008.11.010. Epub 2009 Jan 18.

PMID:
19153062

Supplemental Content

Support Center